SCHEMBL6255385

SCHEMBL6255385

Cc1cc(Nc2cccc(C(=O)O)c2)ccc1-c1cccc(N(C)C(=O)Nc2ccc3ccccc3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 3/20 0.48
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 1/20 0.41
CSNK2A1 P68400 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DGAT1 O75907 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5361579 0.79 KDM4E (0.46) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL5365602 0.76 ROCK2 (0.44) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL7076834 0.74 ALDH1A1 (0.65) MAPTHSD17B10NPC1RAB9AAKR1C3
SCHEMBL5359694 0.74 RAB9A (0.48) GAAMAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL3439123 0.71 MME (0.45) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL2087031 0.70 KDM4E (0.45) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL2083890 0.70 FFAR1 (0.50) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL2087033 0.70 KDM4E (0.45) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL12534118 0.70 MAPT (0.60) KDM4ELMNAGAAMAPTMAPK1
SCHEMBL3439142 0.69 MME (0.44) KDM4ELMNAGAAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572629-A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS Galderma Research & Development, S.N.C. (FR) 2005-09-14 EP claimed
WO-2004052840-A1 COMPOUNDS WHICH MODULATE PPARϜ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-06-24 WO claimed